{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:26:54Z","timestamp":1787002014363,"version":"build-2736575974"},"reference-count":41,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2003,1,31]],"date-time":"2003-01-31T00:00:00Z","timestamp":1043971200000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[2003,1]]},"abstract":"<jats:p>\n                    <jats:bold>OBJECTIVE:<\/jats:bold>\n                    \u2002An assessment of oral symptoms and signs in patients with inflammatory bowel disease (IBD).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>METHODS:<\/jats:bold>\n                    \u2002Fifty\u2010four patients with IBD, 34 with Crohn's disease (CD) and 20 with ulcerative colitis (UC) participated in the study. Forty\u2010two patients without gastrointestinal disease or complaints attending the orthopedic clinic served as controls. Each patient completed a written questionnaire and was subjected to an oral examination.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:<\/jats:bold>\n                    \u2002The main findings of this study were the higher prevalence of halitosis (50%\n                    <jats:italic>vs<\/jats:italic>\n                    10%\n                    <jats:italic>P<\/jats:italic>\n                    \u2003&lt;\u20030.0008), nausea (30%\n                    <jats:italic>vs<\/jats:italic>\n                    7%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2003&lt;\u20030.017) and reflux (regurgitation) (45%\n                    <jats:italic>vs<\/jats:italic>\n                    17%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2003&lt;\u20030.017) in patients with UC, and nausea (50%\n                    <jats:italic>vs<\/jats:italic>\n                    7%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2003&lt;\u20030.026), dry mouth and halitosis (29%\n                    <jats:italic>vs<\/jats:italic>\n                    10%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2003&lt;\u20030.026) and vomiting (41%\n                    <jats:italic>vs<\/jats:italic>\n                    5%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20030.01) in patients with CD, compared with controls. Patients with active CD had a higher prevalence of dry mouth, nausea and vomiting compared with controls (46, 69 and 54%\n                    <jats:italic>vs<\/jats:italic>\n                    10, 7 and 5%, respectively,\n                    <jats:italic>P<\/jats:italic>\n                    \u2003&lt;\u20030.001) and of reflux compared with non\u2010active CD (46%\n                    <jats:italic>vs<\/jats:italic>\n                    5%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2003&lt;\u20030.001). Patients with active UC had a higher prevalence of halitosis and regurgitation (50 and 60%\n                    <jats:italic>vs<\/jats:italic>\n                    10 and 17%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2003&lt;\u20030.001) compared with controls.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSIONS:<\/jats:bold>\n                    \u2002The present study demonstrates increased frequency of oral signs and symptoms in patients with IBD. Patients with active CD had more oral signs compared with non\u2010active CD patients. Manifestations such as nausea, vomiting, regurgitation and dry mouth may have detrimental effects on teeth and soft tissues of the oral cavity. Communication between gastroenterologists and dentists is imperative for success of the overall treatment of their patients.\n                  <\/jats:p>","DOI":"10.1034\/j.1601-0825.2003.00879.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T10:46:09Z","timestamp":1047465969000},"page":"34-40","source":"Crossref","is-referenced-by-count":79,"title":["Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease"],"prefix":"10.1111","volume":"9","author":[{"given":"J","family":"Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Shenkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Stavropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Melzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,1,31]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199106000-00018"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-5089(21)00451-X"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.16.4.249"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(76)80163-1"},{"key":"e_1_2_11_6_1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0016-5085(72)80183-5","article-title":"Crohn's disease of the mouth","volume":"62","author":"Bishop RP","year":"1972","journal-title":"Gastroenterology"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(05)80126-X"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(91)90012-2"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.1981.0334"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0300-5712(92)90019-9"},{"key":"e_1_2_11_11_1","first-page":"194","article-title":"Sulphasalazine induced oral lichen planus","volume":"288","author":"Davies PT","year":"1984","journal-title":"Br Med J"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)91490-3"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3913(79)90196-3"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3913(87)90117-X"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(85)80033-5"},{"key":"e_1_2_11_16_1","first-page":"64","volume-title":"Mosby's dental drug reference","author":"Gage TW","year":"2001"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197609000-00004"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(93)90200-N"},{"key":"e_1_2_11_19_1","first-page":"552","volume-title":"Statistics","author":"Hays WH","year":"1981"},{"key":"e_1_2_11_20_1","first-page":"190","article-title":"Inflammatory bowel disease after 1932","volume":"67","author":"Janowitz HD","year":"2000","journal-title":"Mt Sinai J Med"},{"key":"e_1_2_11_21_1","first-page":"88","article-title":"Extraintestinal manifestations of idiopathic ulcerative colitis","volume":"10","author":"Kochhar R","year":"1991","journal-title":"Indian J Gastroenterol"},{"key":"e_1_2_11_22_1","first-page":"7","article-title":"Prevalence of oral lesions in inflammatory bowel disease","volume":"9","author":"Lisciandrano D","year":"1996","journal-title":"Am J Gastroentrol"},{"key":"e_1_2_11_23_1","first-page":"733","volume-title":"Oral and maxillofacial pathology","author":"Neville BW","year":"2002"},{"key":"e_1_2_11_24_1","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archderm.1978.01640190049017","article-title":"A diffuse pustular eruption associated with ulcerative colitis","volume":"114","author":"O'Loughlin S","year":"1978","journal-title":"Arch Dermatol"},{"key":"e_1_2_11_25_1","first-page":"524","article-title":"Stimulated salivary flow rate, pH, and lactobacillus and yeast concentrations in medicated persons","volume":"92","author":"Parvinen T","year":"1984","journal-title":"Scand J Dent Res"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90863-T"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199102000-00008"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(84)90284-6"},{"key":"e_1_2_11_29_1","first-page":"91","volume-title":"In vitro erosion caused by acidic drinks","author":"Rytomaa I","year":"1987"},{"key":"e_1_2_11_30_1","first-page":"864","article-title":"Crohn's disease of the mouth and lips","volume":"12","author":"Schiller KF","year":"1971","journal-title":"Gut"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(87)80175-2"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.1992.7.3.221"},{"key":"e_1_2_11_33_1","first-page":"594","article-title":"Oral changes in Crohn's disease","volume":"34","author":"Snyder MB","year":"1976","journal-title":"J Oral Surg"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1741-2358.1986.tb00055.x"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70167-9"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(89)90356-3"},{"key":"e_1_2_11_37_1","first-page":"531","article-title":"Oral status in patients with Crohn's disease","volume":"148","author":"Sundh B","year":"1984","journal-title":"Acta Chair Scand"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(72)90369-6"},{"key":"e_1_2_11_39_1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archderm.1985.01660010098029","article-title":"Pyostomatitis vegetans. A reactive mucosal marker for inflammatory disease of the gut","volume":"121","author":"Van\u2010Hale HM","year":"1985","journal-title":"Arch Dermatol"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199607000-00009"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.127.6.889"},{"key":"e_1_2_11_42_1","first-page":"451","article-title":"The clinical entity of orofacial Crohn's disease","volume":"79","author":"Williams AJ","year":"1991","journal-title":"Q J Med"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1601-0825.2003.00879.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1601-0825.2003.00879.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1601-0825.2003.00879.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T02:49:39Z","timestamp":1697165379000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1601-0825.2003.00879.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1034\/j.1601-0825.2003.00879.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1601-0825.2003.00879.x","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}